Whereas the suppressive function was partially or completely inhibited by dopamine when Tregs were obtained from healthy controls or untreated MS patients, respectively, dopamine-mediated inhibition of Treg function was abolished when Tregs were obtained from IFN-β-treated MS patients (66). This evidence concerns the gene IFNB1 and myeloid sarcoma.